» Articles » PMID: 35591182

The Role of Different Retinal Imaging Modalities in Predicting Progression of Diabetic Retinopathy: A Survey

Abstract

Diabetic retinopathy (DR) is a devastating condition caused by progressive changes in the retinal microvasculature. It is a leading cause of retinal blindness in people with diabetes. Long periods of uncontrolled blood sugar levels result in endothelial damage, leading to macular edema, altered retinal permeability, retinal ischemia, and neovascularization. In order to facilitate rapid screening and diagnosing, as well as grading of DR, different retinal modalities are utilized. Typically, a computer-aided diagnostic system (CAD) uses retinal images to aid the ophthalmologists in the diagnosis process. These CAD systems use a combination of machine learning (ML) models (e.g., deep learning (DL) approaches) to speed up the diagnosis and grading of DR. In this way, this survey provides a comprehensive overview of different imaging modalities used with ML/DL approaches in the DR diagnosis process. The four imaging modalities that we focused on are fluorescein angiography, fundus photographs, optical coherence tomography (OCT), and OCT angiography (OCTA). In addition, we discuss limitations of the literature that utilizes such modalities for DR diagnosis. In addition, we introduce research gaps and provide suggested solutions for the researchers to resolve. Lastly, we provide a thorough discussion about the challenges and future directions of the current state-of-the-art DL/ML approaches. We also elaborate on how integrating different imaging modalities with the clinical information and demographic data will lead to promising results for the scientists when diagnosing and grading DR. As a result of this article's comparative analysis and discussion, it remains necessary to use DL methods over existing ML models to detect DR in multiple modalities.

Citing Articles

Gold Nanoparticles for Retinal Molecular Optical Imaging.

Park S, Nguyen V, Wang X, Paulus Y Int J Mol Sci. 2024; 25(17).

PMID: 39273264 PMC: 11395175. DOI: 10.3390/ijms25179315.


Flavoprotein fluorescence elevation is a marker of mitochondrial oxidative stress in patients with retinal disease.

Ahsanuddin S, Rios H, Otero-Marquez O, Macanian J, Zhou D, Rich C Front Ophthalmol (Lausanne). 2024; 3:1110501.

PMID: 38983095 PMC: 11182218. DOI: 10.3389/fopht.2023.1110501.


Identification of key biomarkers for early warning of diabetic retinopathy using BP neural network algorithm and hierarchical clustering analysis.

Li P, Wang H, Tian G, Fan Z Sci Rep. 2024; 14(1):15108.

PMID: 38956257 PMC: 11219780. DOI: 10.1038/s41598-024-65694-x.


CSANet: a lightweight channel and spatial attention neural network for grading diabetic retinopathy with optical coherence tomography angiography.

Ma F, Liu X, Wang S, Li S, Dai C, Meng J Quant Imaging Med Surg. 2024; 14(2):1820-1834.

PMID: 38415109 PMC: 10895115. DOI: 10.21037/qims-23-1270.


An AI-based novel system for predicting respiratory support in COVID-19 patients through CT imaging analysis.

Shawky Farahat I, Sharafeldeen A, Ghazal M, Alghamdi N, Mahmoud A, Connelly J Sci Rep. 2024; 14(1):851.

PMID: 38191606 PMC: 10774502. DOI: 10.1038/s41598-023-51053-9.


References
1.
Mendis K, Balaratnasingam C, Yu P, Barry C, McAllister I, Cringle S . Correlation of histologic and clinical images to determine the diagnostic value of fluorescein angiography for studying retinal capillary detail. Invest Ophthalmol Vis Sci. 2010; 51(11):5864-9. DOI: 10.1167/iovs.10-5333. View

2.
Wilkinson C, Ferris 3rd F, Klein R, Lee P, Agardh C, Davis M . Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003; 110(9):1677-82. DOI: 10.1016/S0161-6420(03)00475-5. View

3.
Arend O, Wolf S, Jung F, Bertram B, Postgens H, Toonen H . Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol. 1991; 75(9):514-8. PMC: 1042463. DOI: 10.1136/bjo.75.9.514. View

4.
Gyawali R, Toomey M, Stapleton F, Zangerl B, Dillon L, Keay L . Quality of the Australian National Health and Medical Research Council's clinical practice guidelines for the management of diabetic retinopathy. Clin Exp Optom. 2021; 104(8):864-870. DOI: 10.1080/08164622.2021.1880862. View

5.
Yannuzzi L, Rohrer K, Tindel L, Sobel R, Costanza M, Shields W . Fluorescein angiography complication survey. Ophthalmology. 1986; 93(5):611-7. DOI: 10.1016/s0161-6420(86)33697-2. View